Transcriptomics reveals new regulatory mechanisms involved in benralizumab response

Allergy. 2023 Nov;78(11):3023-3026. doi: 10.1111/all.15869. Epub 2023 Aug 28.

Miguel Estravís^{1

2}, Jacqueline Pérez-Pazos^{1

3}, Emma Moreno-Jimenez^{1

4}, Juan Carlos Triviño⁵, Asunción García-Sánchez^{1

2

6}, Manuel Gómez-García^{1

3}, Natalia Morgado^{1

6}, Jacinto Ramos-González⁷, María Gil-Melcón⁸, Cristina Martín-García^{1

9}, Francisco Muñoz-Bellido^{1

2

9}, Catalina Sanz^{1

2

4}, María Isidoro-García^{1

2

10

11}, Ignacio Dávila^{1

2

5

9}

¹ Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
² Red de Enfermedades Inflamatorias - Instituto de Salud Carlos III, Madrid, Spain.
³ Clinical Biochemistry Department Salamanca, Pharmacogenetics and Precision Medicine Unit, Hospital Universitario de Salamanca, Salamanca, Spain.
⁴ Microbiology and Genetics Department Salamanca, Universidad de Salamanca, Salamanca, Spain.
⁵ Synlab Group, Sistemas Genómicos SL, Valencia, Spain.
⁶ Biomedical and Diagnostics Sciences Department, Universidad de Salamanca, Salamanca, Spain.
⁷ Pneumology Department, Hospital Universitario de Salamanca, Salamanca, Spain.
⁸ Otorhinolaryngology and Head and Neck Surgery Department, Hospital Universitario de Salamanca, Salamanca, Spain.
⁹ Allergy Department, Hospital Universitario de Salamanca, Salamanca, Spain.
¹⁰ Medicine Department, Universidad de Salamanca, Salamanca, Spain.
¹¹ Clinical Biochemistry Department, Hospital Universitario de Salamanca, Salamanca, Spain.

No abstract available

Publication types